Oxidoreductases: Functions, Mechanisms, and Applications

Explore the diverse roles, mechanisms, and applications of oxidoreductases in biology, industry, and medicine.

Oxidoreductases are the largest class of enzymes in biology, and their job is deceptively simple: they move electrons from one molecule to another. That single trick underlies nearly everything a cell does to stay alive, from extracting energy out of food to building proteins, neutralizing toxic byproducts, and capturing sunlight. Because they show up in so many contexts, oxidoreductases also turn out to be remarkably useful outside of living organisms, powering applications from blood-glucose monitors to pharmaceutical manufacturing and pollution cleanup.

The Core Job in Energy Production

The most familiar role of oxidoreductases is in cellular respiration, the process your cells use to convert nutrients into usable energy. The mitochondrial electron transport chain is essentially a relay of oxidoreductases passing electrons down a gradient, and the energy released at each handoff is harnessed to make ATP, the cell’s energy currency. Complex I is the entry point for most of those electrons: it accepts them from NADH (a molecule produced when you break down sugars and fats) and passes them to a small carrier molecule called ubiquinone. Complex II bridges the electron transport chain with the Krebs cycle, pulling double duty in two central metabolic pathways. Complexes III and IV continue the chain until oxygen, the final electron acceptor, picks up the electrons and combines with hydrogen ions to form water. Recent cryo-electron microscopy work has even captured high-resolution images of these respiratory complexes assembled together in their native arrangements inside intact mitochondria, revealing how they physically cluster into “supercomplexes” that may improve efficiency.

Oxidases Versus Monooxygenases

Not all oxidoreductases handle oxygen the same way, and the distinction matters. Oxidases use molecular oxygen as an electron dump, reducing it to hydrogen peroxide. Monooxygenases do something more surgical: they activate oxygen and insert a single oxygen atom directly into a substrate molecule. Many of these enzymes use flavin (a derivative of vitamin B₂) as a cofactor, and the physical position of the reacting oxygen relative to that flavin group is a key factor in determining which path the enzyme takes.

Cytochrome P450 enzymes are a well-known family of monooxygenases. They belong to a huge superfamily of heme-containing proteins that split molecular oxygen, inserting one atom into an organic substrate and releasing the other as water. The mechanism, sometimes called “hydrogen abstraction–oxygen rebound,” involves the enzyme’s iron-oxo intermediate pulling a hydrogen atom off the substrate to create a fleeting carbon radical, then immediately delivering an oxygen atom to that radical to form the product, typically an alcohol. In your liver, P450 enzymes are the primary machinery for metabolizing drugs and clearing foreign chemicals from your blood. This is why grapefruit juice can interfere with certain medications: compounds in the juice inhibit specific P450 enzymes, slowing drug breakdown and effectively raising the dose in your bloodstream.

How Electrons Move with Such Precision

One of the striking things about oxidoreductases is their stereochemical fidelity. Alcohol dehydrogenases, the enzymes that break down ethanol (and are involved in many other reactions), transfer a hydrogen atom from a very specific face of their nicotinamide cofactor. Yeast alcohol dehydrogenase, for instance, selects the pro-R hydrogen from the cofactor’s nicotinamide ring. The same selectivity holds for alcohol dehydrogenases from thermophilic bacteria and even from archaea, organisms that live in extreme environments like hot acidic springs.

How precise is this selectivity? In native yeast alcohol dehydrogenase, the enzyme makes roughly one stereochemical “mistake” per seven billion turnovers. A single amino acid change at position 182 in the protein drops that to one mistake per 850,000 turnovers, and further cofactor modifications bring it down to one mistake per 450 turnovers. This tells researchers that the enzyme’s active site physically blocks the cofactor from binding in the wrong orientation, and that just one or two amino acid side chains are responsible for maintaining that block. When the barrier is removed by mutation, the cofactor can flip and deliver the wrong hydrogen.

Some oxidoreductases use a more exotic form of electron transfer called electron bifurcation, where a single two-electron input is split into two one-electron outputs traveling along separate paths with very different energy profiles. The enzyme Nfn, found in many anaerobic microorganisms, does exactly this: it takes two electrons from NADPH and sends one along an energetically favorable path and the other along an energetically unfavorable path, using the energy released from the first transfer to drive the second. The fleeting intermediate that makes this possible is an anionic semiquinone, a radical form of flavin so unstable it drives the uphill electron transfer almost instantaneously. Semiquinone intermediates also appear in other flavoprotein oxidoreductases and sometimes indicate that the enzyme is shuttling electrons one at a time rather than as a pair.

Capturing Sunlight

Photosynthesis depends on oxidoreductases at its final step. After sunlight energizes electrons through two photosystems in the chloroplast, those electrons need to end up on NADP⁺ so it becomes NADPH, the reducing power that drives carbon fixation. The enzyme ferredoxin-NADP⁺ reductase (FNR) handles that handoff, accepting electrons from the small protein ferredoxin and using them to reduce NADP⁺.

FNR’s physical location in the chloroplast turns out to regulate which path electrons take. When FNR is tethered to photosystem I, you might expect it to funnel electrons straight into NADP⁺ reduction (the “linear” pathway that directly supports carbon fixation). Surprisingly, recent work in plants found the opposite: anchoring FNR to photosystem I actually promoted cyclic electron transfer at the expense of linear transfer and CO₂ fixation. The enzyme seems to act as a switch: bound to photosystem I, it favors one route; bound to a different complex (cytochrome b₆f), it favors another. This means the plant can tune its energy balance by redistributing a single oxidoreductase between two docking stations.

Building Proteins and Defending Against Damage

Oxidoreductases play essential roles beyond energy metabolism. In the endoplasmic reticulum, where cells build and fold secreted proteins, over 30% of newly made proteins require help forming disulfide bonds, the chemical crosslinks that stabilize a protein’s three-dimensional shape. The enzyme protein disulfide isomerase (PDI) catalyzes disulfide bond formation, reduction, and rearrangement in client proteins. After PDI donates its oxidizing equivalents, a second oxidoreductase called ERO1 recharges PDI by passing electrons ultimately to molecular oxygen, generating hydrogen peroxide as a byproduct. This pathway is essential in simple eukaryotes like yeast, and its disruption in mammals is linked to protein misfolding diseases.

Cells also rely on oxidoreductases to mop up reactive oxygen species, the aggressive byproducts of normal metabolism. Superoxide dismutases convert superoxide radicals into hydrogen peroxide and oxygen. Catalase and various peroxidases then convert that hydrogen peroxide into water, completing a two-step detoxification chain that turns two harmful species into something completely harmless. When these defenses are overwhelmed, oxidative stress accumulates, contributing to aging, neurodegeneration, and many chronic diseases.

When Oxidoreductases Fail

Because complex I sits at the gateway of the electron transport chain, genetic defects in its subunits have outsized consequences. Complex I deficiency is the single most common mitochondrial enzyme deficiency seen in childhood, accounting for up to 30% of pediatric mitochondrial disease cases. The clinical picture is severe: common presentations include Leigh syndrome (a progressive brain disease), other early-onset neurodegenerative disorders, fatal infantile lactic acidosis, and heart muscle thickening. Mutations in complex I genes reduce the enzyme’s activity, but they also trigger secondary damage including increased reactive oxygen species production and changes in mitochondrial structure and membrane voltage. Studies in patient-derived skin cells have confirmed that this elevated oxidative stress and altered membrane potential are central to how the disease progresses, not just a side effect of poor energy production.

Another oxidoreductase implicated in disease is xanthine oxidoreductase, the enzyme responsible for the final steps of purine metabolism in humans. It converts hypoxanthine to xanthine and xanthine to uric acid. When uric acid accumulates, it crystallizes in joints, causing gout. Drugs that inhibit xanthine oxidoreductase, like allopurinol and febuxostat, are standard therapy for gout and hyperuricemia. There has been interest in repurposing these inhibitors for broader conditions, including cancer, but the enzyme has complicated roles in signaling and immune defense. Inhibiting it produces effects that are hard to predict outside the straightforward hyperuricemia setting.

Glucose Monitors and Other Biosensor Applications

The glucose biosensor in a diabetic patient’s test strip is one of the most commercially successful applications of an oxidoreductase. The sensor relies on glucose oxidase, a flavin-containing enzyme that oxidizes glucose, producing gluconic acid and hydrogen peroxide. The hydrogen peroxide is then oxidized at a platinum electrode, generating a measurable electrical current proportional to the glucose concentration in blood. More recent designs use nanomaterials like graphene to achieve direct electron transfer between the enzyme and the electrode, which can improve sensitivity and reduce interference. Graphene-based glucose oxidase sensors have demonstrated linear response up to 14 mM glucose, covering most of the clinically relevant range. The same principle, immobilize an oxidoreductase that is specific for your target molecule and measure the resulting electron flow, has been adapted for lactate, cholesterol, and alcohol detection.

Pharmaceutical Manufacturing

Many drugs contain a chiral center, a carbon atom bonded to four different groups, and the two mirror-image forms of the molecule can have completely different biological effects. Chemical synthesis often produces a 50-50 mix of both forms, but oxidoreductases called ketoreductases can convert a ketone precursor into just one mirror-image alcohol with extraordinary selectivity. In screening campaigns for generic drug intermediates, researchers tested over 400 commercially available ketoreductases against eight precursor ketones and found productive enzymes for five of them, typically achieving selectivity above 99.5% for the desired form. These reactions scaled smoothly to one-liter volumes while retaining that selectivity, and in many cases both mirror-image products could be produced by simply choosing a different enzyme from the library. The breadth of available ketoreductases has expanded rapidly, making them a practical option for generating chiral drug intermediates.

Cleaning Up Pollution

Lignin, the tough polymer that gives wood its rigidity, is one of the most stubbornly difficult organic materials to break down. White-rot fungi have evolved a battery of oxidoreductases to crack it apart: laccases, lignin peroxidases, manganese peroxidases, and versatile peroxidases. Laccases and manganese peroxidases attack the easier phenolic parts of lignin directly, while lignin peroxidase and versatile peroxidase can tackle the more resistant non-phenolic components. None of these enzymes are particularly picky about what they oxidize, and that promiscuity is actually an advantage. It means they can be repurposed for breaking down synthetic dyes, pharmaceuticals, and other organic pollutants in wastewater. Small helper molecules called mediators further expand the range of substrates these enzymes can reach, including compounds that the enzyme alone cannot oxidize because of their size or chemical structure.

Engineering Better Oxidoreductases

Wild-type oxidoreductases rarely survive the harsh conditions of an industrial reactor. They evolved to work at body temperature, neutral pH, and low substrate concentrations. Directed evolution, the lab-based approach of introducing random mutations and screening for improved variants, has proven remarkably effective at closing this gap.

A thermostable phosphite dehydrogenase, for example, was engineered through three rounds of random mutation and screening. The final variant had a temperature midpoint 20 °C higher than the starting enzyme and a half-life of thermal inactivation over 7,000-fold longer at 45 °C, all while slightly improving its catalytic efficiency. That enzyme is useful not for its own reaction but as a cofactor recycling system: it regenerates the expensive NADPH consumed by other oxidoreductases during industrial bioconversions, drastically reducing costs.

Galactose oxidase, an enzyme of interest for converting sugars and alcohols, has been improved by combining directed evolution with computational protein design. After two rounds of random mutagenesis, one variant showed a twofold improvement in thermostability at 70 °C and enhanced activity on both galactose and glucose. A parallel computational approach introduced 31 mutations outside the active site, boosting stability without sacrificing activity. Ligninolytic oxidoreductases have been similarly stabilized through mutant library screening in yeast, with stabilizing mutations typically found at the protein surface where they form new interactions with neighboring residues.

Light-Driven Reactions and Green Chemistry

One of the more exciting recent developments is pairing oxidoreductases with light. Many industrial biocatalytic reactions require a constant supply of electrons, which traditionally comes from sacrificial chemical reagents that generate waste. Photocatalytic materials can harvest light energy and deliver electrons directly to oxidoreductases, replacing those chemical inputs with renewable solar energy. This fusion of photocatalysis and enzyme catalysis not only reduces waste but also opens the door to reactions that neither approach could achieve alone. A photocatalyst absorbs a photon and generates an excited electron; that electron reduces a cofactor or a mediator, which in turn feeds the enzyme’s catalytic cycle. The approach has been demonstrated with several classes of oxidoreductases and is under active development for applications ranging from fine chemical synthesis to fuel production.

Evolutionary Roots

The diversity of modern oxidoreductases traces back to ancient evolutionary events. Fumarate reductases and succinate dehydrogenases, enzymes that catalyze closely related reactions in opposite directions, belong to a superfamily that appears to have emerged from a single common ancestor. These enzymes were likely essential for the development of early metabolic pathways involved in energy conversion, predating the split between aerobic and anaerobic lifestyles. Nitrogen fixation, the biologically critical process of converting atmospheric N₂ into ammonia, depends on nitrogenase, an oxidoreductase that uses eight electrons and sixteen ATP molecules per molecule of nitrogen fixed. Nitrogenase is restricted to certain bacteria and archaea, many of which live in symbiosis with plant roots, but the ammonia it produces sustains nearly all life on Earth by feeding the nitrogen cycle. The enzyme’s deep evolutionary conservation and its energetically costly mechanism highlight how central electron-transfer chemistry has been since the earliest stages of life.